Literature DB >> 23594575

Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013.

T Kageyama1, S Fujisaki, E Takashita, H Xu, S Yamada, Y Uchida, G Neumann, T Saito, Y Kawaoka, M Tashiro.   

Abstract

Novel influenza viruses of the H7N9 subtype have infected 33 and killed nine people in China as of 10 April 2013. Their haemagglutinin (HA) and neuraminidase genes probably originated from Eurasian avian influenza viruses; the remaining genes are closely related to avian H9N2 influenza viruses. Several characteristic amino acid changes in HA and the PB2 RNA polymerase subunit probably facilitate binding to human-type receptors and efficient replication in mammals, respectively, highlighting the pandemic potential of the novel viruses.

Entities:  

Mesh：

Year:  2013        PMID： 23594575      PMCID： PMC6296756     

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  156 in total

1.  A novel eight amino acid insertion contributes to the hemagglutinin cleavability and the virulence of a highly pathogenic avian influenza A (H7N3) virus in mice.

Authors:  Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Virology       Date:  2015-11-26       Impact factor: 3.616

2.  Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic.

Authors:  Wanda I Santana; Tracie L Williams; Emily K Winne; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2014-04-11       Impact factor: 6.986

3.  Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic.

Authors:  Justin J O'Hagan; Karen K Wong; Angela P Campbell; Anita Patel; David L Swerdlow; Alicia M Fry; Lisa M Koonin; Martin I Meltzer
Journal:  Clin Infect Dis       Date:  2015-05-01       Impact factor: 9.079

4.  Human H7N9 influenza A viruses replicate in swine respiratory tissue explants.

Authors:  J C Jones; T Baranovich; H Zaraket; Y Guan; Y Shu; R J Webby; R G Webster
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

5.  Impact of route of exposure and challenge dose on the pathogenesis of H7N9 low pathogenicity avian influenza virus in chickens.

Authors:  Erica Spackman; Mary Pantin-Jackwood; David E Swayne; David L Suarez; Darrell R Kapczynski
Journal:  Virology       Date:  2015-02-06       Impact factor: 3.616

6.  Deadly H7N9 influenza virus: a pandemic in the making or a warning lesson?

Authors:  Robert A Lamb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

7.  Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin.

Authors:  Peter H Goff; Florian Krammer; Rong Hai; Christopher W Seibert; Irina Margine; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

8.  Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses.

Authors:  Gabriele Neumann; Catherine A Macken; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Authors:  Natalie J Thornburg; Heng Zhang; Sandhya Bangaru; Gopal Sapparapu; Nurgun Kose; Rebecca M Lampley; Robin G Bombardi; Yingchun Yu; Stephen Graham; Andre Branchizio; Sandra M Yoder; Michael T Rock; C Buddy Creech; Kathryn M Edwards; David Lee; Sheng Li; Ian A Wilson; Adolfo García-Sastre; Randy A Albrecht; James E Crowe
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

10.  Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission.

Authors:  Qinfang Liu; Bin Zhou; Wenjun Ma; Bhupinder Bawa; Jingjiao Ma; Wei Wang; Yuekun Lang; Young Lyoo; Rebecca A Halpin; Xudong Lin; Timothy B Stockwell; Richard Webby; David E Wentworth; Juergen A Richt
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.